newsfilter
← Latest News
GlobeNewswire·

Lyell Immunopharma To Participate in November Investor Events

  • Lyell Immunopharma senior management will participate in the Goldman Sachs RxChange Series fireside chat on November 5, 2026, featuring Dr. Alexander P. Boardman to discuss next-generation lymphoma CAR-T data.
  • The company will attend the Stifel 2026 Healthcare Conference on November 10, 2026, for fireside chat & 1x1 meetings, with a live webcast available on www.lyell.com.
  • Lyell Immunopharma will hold 1x1 meetings at the 2026 Jefferies Global Healthcare Conference on November 18, 2026.
  • Lyell is a late-stage clinical company developing next-generation CAR T-cell therapies for hematologic malignancies & solid tumors.
  • The company's proprietary LyFE Manufacturing Center has commercial launch capability & an expected annual capacity of over 1,200 CAR T-cell doses.